Compare JSPR & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JSPR | AEYE |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | N/A | 116 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 86.2M |
| IPO Year | 2019 | 2011 |
| Metric | JSPR | AEYE |
|---|---|---|
| Price | $0.63 | $6.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $15.50 | $14.63 |
| AVG Volume (30 Days) | ★ 339.9K | 183.3K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.22 | ★ 30.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,311,000.00 |
| Revenue This Year | N/A | $11.12 |
| Revenue Next Year | N/A | $11.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.52 |
| 52 Week Low | $0.32 | $5.31 |
| 52 Week High | $2.69 | $16.39 |
| Indicator | JSPR | AEYE |
|---|---|---|
| Relative Strength Index (RSI) | 47.76 | 44.54 |
| Support Level | $0.56 | $6.61 |
| Resistance Level | $0.67 | $7.40 |
| Average True Range (ATR) | 0.05 | 0.44 |
| MACD | -0.00 | -0.11 |
| Stochastic Oscillator | 48.41 | 10.23 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences. It generates revenue through the sale of subscriptions for software-as-a-service (SaaS). accessibility solutions.